One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery DiseaseA Post Hoc Secondary Analysis of the AFIRE Trial
Ryo Naito, MD, MSc, PhD; Katsumi Miyauchi, MD, PhD; Satoshi Yasuda, MD, PhD; Koichi Kaikita, MD, PhD; Masaharu Akao, MD, PhD;Junya Ako, MD, PhD; Tetsuya Matoba, MD, PhD; Masato Nakamura, MD, PhD; Nobuhisa Hagiwara, MD, PhD; Kazuo Kimura, MD, PhD;Atsushi Hirayama, MD, PhD; Kunihiko Matsui, MD, MPH; Hisao Ogawa, MD, PhD; for the AFIRE Investigators
doi : 10.1001/jamacardio.2022.1561
August 2022, Vol 7, No. 8, Pages 780-878
Association of Sitting Time With Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries
Sidong Li, BM; Scott A. Lear, PhD; Sumathy Rangarajan, MSc; Bo Hu, PhD; Lu Yin, PhD;Shrikant I. Bangdiwala, PhD; Khalid F. Alhabib, MBBS; Annika Rosengren, PhD; Rajeev Gupta, PhD;Prem K. Mony, MD; Andreas Wielgosz, PhD; Omar Rahman, DSc; M. Y. Mazapuspavina, MMedFamMed;Alvaro Avezum, PhD; Aytekin Oguz, MD; Karen Yeates, MD; Fernando Lanas, PhD; Antonio Dans, PhD;Marc Evans M. Abat, MD; Afzalhussein Yusufali, MD; Rafael Diaz, MD; Patricio Lopez-Jaramillo, PhD;Lloyd Leach, PhD; P. V. M. Lakshmi, MD; Alicja Basiak-Rasała, PhD; Romaina Iqbal, PhD; Roya Kelishadi, MD;Jephat Chifamba, DPhil; Rasha Khatib, PhD; Wei Li, PhD; Salim Yusuf, DPhil
External Support for Saphenous Vein Grafts in Coronary Artery Bypass SurgeryA Randomized Clinical Trial
Daniel J. Goldstein, MD; John D. Puskas, MD; John H. Alexander, MD; Helena L. Chang, MS; James S. Gammie, MD;Mary E. Marks, RN, BSN; Alexander Iribarne, MD, MS; Yuliya Vengrenyuk, PhD; Samantha Raymond, MPH;Bradley S. Taylor, MD; Orit Yarden, PhD; Eyal Orion, MD, MBA; François Dagenais, MD; Gorav Ailawadi, MD;Michael W. A. Chu, MD; J. Michael DiMaio, MD; Jagat Narula, MD, PhD; Ellen G. Moquete, RN, BSN;Karen O’Sullivan, MPH; Judson B. Williams Jr, MD, MHS; Juan A. Crestanello, MD; Mariell Jessup, MD;Eric A. Rose, MD; Vincent Scavo, MD; Michael A. Acker, MD; Marc Gillinov, MD; Michael J. Mack, MD;Annetine C. Gelijns, PhD; Patrick T. O’Gara, MD; Alan J. Moskowitz, MD; Emilia Bagiella, PhD; Pierre Voisine, MD
Effectiveness and Safety of Early Initiation of Poststernotomy Cardiac Rehabilitation Exercise TrainingThe SCAR Randomized Clinical Trial
Stuart Ennis, PhD; Grace Lobley, MSc; Sandra Worrall, BSc; Becky Evans, MSc; Peter K. Kimani, PhD;Amir Khan, PhD; Richard Powell, BSc; Prithwish Banerjee, MD, PhD; Tom Barker, MD, PhD; Gordon McGregor, PhD
Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function
Sripal Bangalore, MD, MHA; Judith S. Hochman, MD; Susanna R. Stevens, MS; Philip G. Jones, MS; John A. Spertus, MD, MPH;Sean M. O’Brien, PhD; Harmony R. Reynolds, MD; William E. Boden, MD; Jerome L. Fleg, MD; David O. Williams, MD; Gregg W. Stone, MD;Mandeep S. Sidhu, MD; Roy O. Mathew, MD; Glenn M. Chertow, MD; David J. Maron, MD
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines
Martin Bødtker Mortensen, MD, PhD1,2,3,4; Anne Tybjærg-Hansen, MD, DMSc3,4,5; Børge G. Nordestgaard, MD, DMSc2,3,4
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure
Matthew W. Segar, MD, MS; Jennifer L. Hall, PhD; Pardeep S. Jhund, MBChB, MSc, PhD; Tiffany M. Powell-Wiley, MD, MPH;Alanna A. Morris, MD, MSc; David Kao, MD; Gregg C. Fonarow, MD; Rosalba Hernandez, PhD; Nasrien E. Ibrahim, MD;Christine Rutan, BS; Ann Marie Navar, MD, PhD; Laura M. Stevens, PhD; Ambarish Pandey, MD, MSCS
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry
Behnood Bikdeli, MD, MS; César Caraballo, MD; Javier Trujillo-Santos, MD, PhD; Jean Philippe Galanaud, MD, PhD;Pierpaolo di Micco, MD, PhD; Vladimir Rosa, MD, PhD; Gemma Vidal Cusidó, MD; Sebastian Schellong, MD, PhD;Meritxell Mellado, MD, PhD; MarÃa del Valle Morales, MD; Olga GavÃn-Sebastián, MD, PhD;Lucia Mazzolai, MD, PhD; Harlan M. Krumholz, MD, SM; Manuel Monreal, MD, PhD; for the RIETE Investigators
Antiabortion Laws and Implications for Patients With Cardiovascular Disease in Pregnancy
Verity N. Ramirez, MD1; Melissa Ferraro-Borgida, MD2; Sarah Lindsay, MD3,4
Medicine, Writing, and the Limits of Language
Harold L. Dauerman, MD1
Time to Revisit Using 10-Year Risk to Guide Statin Therapy
Ann Marie Navar, MD, PhD1,2; Gregg C. Fonarow, MD3,4; Michael J. Pencina, PhD5,6
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery DiseaseDoes Less Mean More?
Ying X. Gue, MBChB, PhD1; Diana A. Gorog, MBBS, MD, PhD2,3; Gregory Y. H. Lip, MD1,4
Machine Learning and Social Determinants of Health—An Opportunity to Move Beyond Race for Inpatient Risk Prediction in Patients With Heart Failure
Eldrin F. Lewis, MD, MPH1
Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve ReplacementA Review
Thomas J. Cahill, MB, BS, DPhil; Ajay J. Kirtane, MD, SM; Martin Leon, MD; Susheel K. Kodali, MD
A Young Man With Syncope
Asad J. Torabi, MD1; Mark Kauth, MD1; Takeki Suzuki, MD, PhD2
An Older Woman With a Mobile Right Atrial Mass
Olina Dagher, MD1,2; Philippe Joubert, MD, PhD3; Michel Pellerin, MD1
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation
Tasuku Terada, CEP, PhD1; Sol Vidal-Almela, CEP, MSc1,2; Jennifer L. Reed, RKin, PhD1,3
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation
Erik H. Van Iterson, PhD1; Luke J. Laffin, MD1; Leslie Cho, MD1
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Receiving Cardiovascular Rehabilitation—Reply
Sherrie Khadanga, MD1; Patrick D. Savage, MS1; Philip A. Ades, MD1
Michael Servetus, Doctor of Medicine
Miguel �ngel Cobos Gil, MD, PhD1
Michael Servetus, Doctor of Medicine—Reply
Arman Zargaran, PharmD, PhD1
Explanation for Error in Types of Medicare Patients Included in Aortic Valve Replacement Study
Mabel Chung, MD, MPH1
Replacing Race With Social Determinants of Health in Risk Prediction—Getting It Right
Clyde W. Yancy, MD, MSc1,2; Sadiya S. Khan, MD, MSc1,3,4
